Higher-load RT produces similar effects in individuals with type 2 diabetes (T2D) [64,65], potentially due to upregulated glucose transporter (GLUT) proteins and increased insulin receptor density in muscle cells [66]. The gene discussed is SLC2A1; the disease is type 2 diabetes mellitus.